Navigation Links
International Isotopes Inc. Announces Third Quarter and Nine Months 2008 Financial Results
Date:11/11/2008

ne-month period ending September 30, 2008, was $527,532 compared to $503,877 for the same period in 2007. This represents an increase in revenue of $23,655 or approximately a 5% increase. The fluctuations in revenue from this segment were attributable to typical variations in the volume of gemstone processing.

Gross profit for the three and nine-month periods ended September 30, 2008, was $597,282 and $2,246,355 compared to $689,849 and $1,618,879 for the same periods in 2007. This represents a decrease of $92,567 or 13% and an increase of $627,476 or 39%, for the three and nine month periods respectively. However, gross profit as a percentage of revenue grew from 46% to 48% for the three-month period and from 45% to 50% for the nine-month period comparisons. The Company reported the improvement in gross profit percentage was the result of improvements in production costs and production efficiencies.

Operating expenses increased to $1,324,266 and $3,647,443 for the three and nine-month period ended September 30, 2008, compared to $970,115 and $2,756,052 for the same periods of 2007. This represents an increase of $354,151 or 36%, and $891,391 or 32%, for the three and nine-month periods respectively. The Company reports operating costs have increased in the period comparisons due to increased salaries, contract labor, and legal expense related to engineering design, licensing, addition of full time staff, subcontractors, and legal counsel necessary to support continued growth of the fluorine products division. This includes pilot plant demonstrations and efforts related to equipment acquisition, raising capital, and protecting newly developed intellectual property.

The Company's net loss for the three and nine-month periods ended September 30, 2008 was $739,161 and $1,451,815 compared to a loss of $276,287 and $1,146,281 for the same periods in 2007. This increase in loss was attributable to increases in operating costs related to the support an
'/>"/>

SOURCE International Isotopes Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. U of T professor first Canadian woman to win prestigious international science prize
2. Chindex International Inc. Reports Second Quarter FY 2009 Financial Results
3. Health Care Workers Get Help Fighting Unprecedented Attacks from Service Employee International Union Leadership
4. Ceasefire Broken in Democratic Republic of Congo; International Medical Corps Warns of Looming Humanitarian Catastrophe and Wider Regional Impact
5. Easter Seals Elects Kent Schien, Chief Executive Officer of St. Louis-based Innoventor, to the Organizations International Board of Directors
6. Schiff(R) Nutrition International Declares November Give Thanks for Grandparents Month
7. DATATRAK International, Inc. Announces 2008 Third Quarter and Nine Month Operating Results
8. Joslin researcher named first winner of the Manpei Suzuki International Prize for Diabetes Research
9. Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board
10. EarthSearch Communications International Joins Motorola's Enterprise Mobility Business PartnerSelect Program
11. International Medical Corps Continues Delivering Emergency Relief in Democratic Republic of Congo as Potential for Renewed Fighting Threatens to Deepen Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... September 15, 2014 Insurers across ... that bring providers on board as partners to ... When bundled payment programs are designed properly they ... incentivize hospitals to work collaboratively with providers, and ... On Sept. 24, the Atlantic Information Services webinar, ...
(Date:9/15/2014)... With a simple swab of the cheek, the ... to help personalize the treatment for patients with vascular disorders, ... approach to medicine is preventive care. But, it can be ... respond to specific drugs. A simple cheek swab test can ... physician to tailor medical therapy and optimize outcomes. , “By ...
(Date:9/15/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on sterile drug products ... FDA, the Agency announced on September 9, that it ... recall of all lots of its purportedly ... expired due to lack of sterility assurance. , In ...
(Date:9/15/2014)... Fancyflyingfox.com, the distinguished wedding dress manufacturer and ... beach wedding dresses . All clients can enjoy a ... up to 70 percent off. According to the company’s ... its loyal customers by launching the current sale. ... 300 different styles of special occasion gowns are provided. ...
(Date:9/14/2014)... 2014 Skin becomes dryer with age. Some ... and not moisturizing properly. However, there are inevitable internal factors ... for. , Two main reasons this occurs: , 1) Loss ... in the skin , During the aging process, skin produces ... responsible for important moisture retention and radiance of skin. ...
Breaking Medicine News(10 mins):Health News:Sept. 24 Webinar to Profile Geisinger Health System, BCBS of North Carolina’s Successful Bundled-Payment Programs 2Health News:Center for Vascular Medicine Offers Genetic Testing For Personalized Vascular Care 2Health News:FDA Requests Recall of Sterile Drug Products by Downing Labs (aka NuVision Pharmacy): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Great Discounts On Beach Wedding Dresses Announced By Fancyflyingfox.com Now 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 3
... when added to existing meds, study finds , , ... helps relieve neuropathic pain in people with HIV, ... of Medicine study. , It included 28 HIV ... by opiates or other pain relievers. The researchers ...
... Increases 2008 Net Sales Projections; Affirms Top End of Adjusted* ... Earnings Guidance --, ... global specialty pharmaceutical and medication,delivery company, today reported results for the second quarter ... during the second quarter of 2008, compared to $869.3 ...
... Inclusion for Key, Emerging Biologic Agents That Will Launch ... Years, According to a ... 6 Decision Resources, one of the,world,s leading research ... 89 percent of surveyed rheumatologists,anticipate prescribing Roche/Chugai,s Actemra, following ...
... Aduromed Begins Next Step in Corporate Evolution, Restructuring the Company ... and Augmenting its Board and Management Team, ... Board: ADRM) a leading manufacturer of medical waste,treatment systems, today ... raise of $3.8 million of new equity capital. As,part of ...
... Software, Inc. today,announced the worldwide launch of iFastrack, ... software for reducing business,risk by tracking insurance certificates ... to manage their risk from,uninsured contractors, vendors or ... proof of insurance at the onset of a ...
... Increase Revenues by Up to $2 Million This ... Corporation (OTC,Bulletin Board: BDRR), a medical imaging and ... Imaging, Inc. has entered into,a joint venture (JV) ... Basic Solutions, Inc. will offer mobile cardiac stress ...
Cached Medicine News:Health News:Medicinal Marijuana Eases Neuropathic Pain in HIV 2Health News:Hospira Reports Second-Quarter 2008 Results 2Health News:Hospira Reports Second-Quarter 2008 Results 3Health News:Hospira Reports Second-Quarter 2008 Results 4Health News:Hospira Reports Second-Quarter 2008 Results 5Health News:Hospira Reports Second-Quarter 2008 Results 6Health News:Hospira Reports Second-Quarter 2008 Results 7Health News:Hospira Reports Second-Quarter 2008 Results 8Health News:Hospira Reports Second-Quarter 2008 Results 9Health News:Hospira Reports Second-Quarter 2008 Results 10Health News:Hospira Reports Second-Quarter 2008 Results 11Health News:Hospira Reports Second-Quarter 2008 Results 12Health News:Hospira Reports Second-Quarter 2008 Results 13Health News:Hospira Reports Second-Quarter 2008 Results 14Health News:Hospira Reports Second-Quarter 2008 Results 15Health News:Hospira Reports Second-Quarter 2008 Results 16Health News:Hospira Reports Second-Quarter 2008 Results 17Health News:Hospira Reports Second-Quarter 2008 Results 18Health News:Hospira Reports Second-Quarter 2008 Results 19Health News:Hospira Reports Second-Quarter 2008 Results 20Health News:Hospira Reports Second-Quarter 2008 Results 21Health News:Hospira Reports Second-Quarter 2008 Results 22Health News:Hospira Reports Second-Quarter 2008 Results 23Health News:Hospira Reports Second-Quarter 2008 Results 24Health News:Hospira Reports Second-Quarter 2008 Results 25Health News:Hospira Reports Second-Quarter 2008 Results 26Health News:Hospira Reports Second-Quarter 2008 Results 27Health News:Hospira Reports Second-Quarter 2008 Results 28Health News:Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugai's Actemra for Rheumatoid Arthritis 2Health News:Eighty-Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche/Chugai's Actemra for Rheumatoid Arthritis 3Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 2Health News:Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital 3Health News:GG-One Software Announces iFastrack to Help Avoid Insurance Disasters 2Health News:Bederra Corp.'s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions 2
(Date:9/15/2014)... LONDON , BERLIN and ... The global market has the potential to grow to ... leading provider of market research reports has announced pharma industry ... Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable ... in terms of US pricing structures and the anticipated approval ...
(Date:9/15/2014)... GENEVE , September 15, 2014 /PRNewswire/ ... des principaux fabricants européens de sortir ou ... marché ou au soutien réglementaire de la ... alcaloïdes tropaniques comme principes pharmaceutiques actifs (API), ... la nortropine, le méthylbromure d,homatropine, le bromhydrate d,homatropine, ...
(Date:9/14/2014)... DIEGO , Sept. 14, 2014 HUYA ... global development of China,s pharmaceutical ... Institute of Pharmaceutical Research (TIPR) to develop medical ... and the western world, for global markets. ... venture, to be known as TIPR-HUYA Advancing Innovative Medicines ...
Breaking Medicine Technology:Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019 2Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019 3Alchem International s'engage à poursuivre et étendre la production des principes pharmaceutiques actifs contenant des alcaloïdes tropaniques et à soutenir la réglementation pour combler l'écart d'approvisionnement 2Alchem International s'engage à poursuivre et étendre la production des principes pharmaceutiques actifs contenant des alcaloïdes tropaniques et à soutenir la réglementation pour combler l'écart d'approvisionnement 3HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 2HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 3HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 4
... (Nasdaq: ARAY ), the premier radiation ... Especialidad in Monterrey, Mexico has starting treating patients with ... is the first center in Mexico now offering patients ... anywhere in the body. The CyberKnife System ...
... Jan. 17, 2012  Ventana Medical Systems, Inc. (Ventana), ... that it has entered into a strategic collaboration ... a molecular companion diagnostic test intended to identify ... Bayer antibody-drug conjugate (ADC). Ventana,s diagnostic immunohistochemistry platform ...
Cached Medicine Technology:First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 2First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 3First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 4Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 2Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 3
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr...
... Manage and Retrieve a ... DVMR- office, the first digital ... the physician's office environment. DVMR ... of high-resolution cameras for simple ...
Research Grade Microscope Camera from ImagingPlanet Research Microscopy Group, a superior imaging technology that delivers increased image resolution and precise color accuracy at an affordable pric...
Medicine Products: